We concur with the court’s ruling that Illumina’s European Patent (EP) 1 828 412 to methods of sequencing by synthesis using ascorbic acid is invalid for obviousness and that MGI’s CoolMPS sequencing method does NOT infringe this patent, and also the finding that MGI’s CoolMPS sequencing does NOT infringe the EP 2 021 415 to […]
SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) today announced that the High Court of Justice, Chancery Division, Patents Court, issued a judgment in its favor in the patent infringement suit filed against the BGI Companies, MGI Tech Co. Ltd; Latvia MGI SIA; MGI International Sales Co., Ltd; and BGI Complete Genomics Hong Kong Co., Ltd. […]
TUCSON, Ariz. — HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that it has received notification of the issuance of Canadian patent number 2877729 for “Nuclease Protection Methods for Detection of Nucleotide Variants.” The patented technology involves a nuclease protection method using wildtype […]
Murrieta Genomics has announced that SimplSeq, Inc., a wholly owned subsidiary, has filed its fourth patent application to protect a new sample preparation technology that is designed to simplify the process for extracting, isolating, purifying and replicating DNA and RNA from biologic samples. “Our internal validation testing has delivered some very exciting data, and we […]
Patented UST Platform, with Unique Ability to Prepare High Quality Commercial Scale Nanoemulsions, Expected to Significantly Impact PBI’s Growth and Profitability in 2021 SOUTH EASTON, Mass. — Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” or the “Company”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform solutions to the worldwide […]
A Research Collaboration Between LuminUltra, Dalhousie University and Halifax Water Demonstrates Wastewater Data Is a Powerful Tool in Early Detection and Tracking COVID-19 Prevalence within Communities FREDERICTON, NB – LuminUltra, a Canada-based biotechnology leader and portfolio company of XPV Water Partners, recently filed a patent for the first complete, rapid, and on-site COVID-19 wastewater testing solution that […]
ERS Genomics announces agreement with FASMAC to commercialize CRISPR/Cas9 research reagents in Japan
Food analysis and biotechnology company licenses gene editing technology Dublin, Ireland, and Kanagawa, Japan: ERS Genomics Limited (“ERS”), which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property (IP) co-owned by Dr. Emmanuelle Charpentier, today announced it has signed an agreement with FASMAC Co., Ltd (“FASMAC”) of Japan. Under the terms of the […]
Licenses aim to accelerate drug discovery leading to development of new therapies PanCELLa agreement marks MilliporeSigma’s first CRISPR license for bioproduction Takara Bio USA agreement gives access to MilliporeSigma’s CRISPR integration and vector technologies for Takara’s vector products and cell engineering services MilliporeSigma today announced that it has signed agreements licensing its CRISPR technology to two […]
Berlin, Germany – Bruker and Oxford Instruments have announced that they have reached a settlement on a patent related issue with Bruker’s Cube product. The agreement licences Bruker the Oxford Instruments patents relating to the design of low noise charge sensitive amplifiers (CSAs) of which Cube is an example. These CSAs are key components in […]
Oxford Instruments plc and Bruker Corporation have announced that they have reached a settlement on a patent related issue with Bruker’s Cube product. The agreement licences Bruker the Oxford Instruments patents relating to the design of low noise charge sensitive amplifiers (CSAs) of which Cube is an example. These CSAs, are key components in a […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
